Skip to main content
. Author manuscript; available in PMC: 2018 Nov 29.
Published in final edited form as: Clin Infect Dis. 2017 Nov 29;65(12):1977–1983. doi: 10.1093/cid/cix724

Table 4.

Effectiveness of Maternal Tdap Vaccination at Preventing Infant Pertussis Hospitalizations, by Timing of Vaccination

Cases Controls Multivariable VEa, % (95% CI)
Total 157 % 336 %
Unvaccinated 76 48.4 109 32.4 REFERENCE
Before pregnancy 16 10.2 46 13.7 76.2 (37.2 – 91.0)
1st or 2nd trimester 2 1.3 20 6.0 91.4 (24.8 – 99.0)
3rd trimester 6 3.8 47 14.0 90.5 (65.2 – 97.4)
After pregnancy 57 36.3 114 33.9 32.5 (−23.5 – 63.1)

Abbreviations: CI, confidence interval; VE, vaccine effectiveness

a

The following variables were included in the final model: household size >2 persons, maternal education, household member with pertussis diagnosis, and infant age (weeks).